The Online Investor

Horizon Therapeutics Plc Stock Forecast

Recent Horizon Therapeutics Plc Stock Price   Horizon Therapeutics Plc Stock Forecast Price
$0.00 Horizon Therapeutics Plc stock forecast: same
NA%
$0.00
 As of
Recent Horizon Therapeutics Plc Analyst Ratings Breakdown
  Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong buy ratings:
Buy ratings:
Hold ratings:
Sell ratings:
Strong sell ratings:
Average rating:
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.

The presented Horizon Therapeutics Plc stock forecast (traded under symbol HZNP), for forward-twelve-months price target as shown at the top of this page, gives you the average Horizon Therapeutics Plc stock forecast for forward target price for symbol HZNP, across the analysts covering Horizon Therapeutics Plc (HZNP), as reported in data provided by Zacks Investment Research via Quandl.com.

Investors should also take note that the median Horizon Therapeutics Plc stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Horizon Therapeutics Plc stock forecast and half had a lower Horizon Therapeutics Plc stock forecast) was $ as of (which is a different mathematical metric versus taking the average or mean), while the highest Horizon Therapeutics Plc stock forecast in the analyst group was $, and the lowest Horizon Therapeutics Plc stock forecast in the analyst group was $, with a standard deviation of $. Get the latest Zacks research report on HZNP — FREE

Slideshow Top Analyst Picks of the Dow
Slideshow The Top 20 Largest U.S. Stocks By Market Cap

Company Name: 
Horizon Therapeutics Plc
Website: 
www.horizontherapeutics.com
Sector: 
Biotechnology
Number of ETFs Holding HZNP: 
1
Total Market Value Held by ETFs: 
$14.90M
Total Market Capitalization: 
$26.62B
% of Market Cap. Held by ETFs: 
0.06%
Quotes delayed 20 minutes

Email EnvelopeFree HZNP Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Horizon Therapeutics Plc Stock Forecast (HZNP) Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.